IBD in Pregnancy

The decision that matters is made before you conceive

Across inflammatory bowel disease guidance the same principle recurs: the state of your disease when you conceive shapes the pregnancy more than any individual drug does. Crohn's and Colitis UK puts the headline plainly on its pregnancy pages: most women with Crohn's or colitis "will have normal pregnancies and healthy babies", and most "can give birth vaginally". Their guidance is that your IBD team and your maternity team should work together so that you are in the best possible health during pregnancy.

The practical reading of that is unglamorous. If your disease is quiet, the aim is to keep it quiet. If it is active, the aim is to get it into remission, ideally before conception, and that usually means more treatment rather than less.

Why stopping your medicine is the risk, not the safe option

The most common self-directed decision in IBD pregnancy is stopping maintenance treatment on seeing a positive test. It is understandable and it is usually the wrong move, because a flare in pregnancy is itself associated with worse outcomes and is harder to treat once it has started than to prevent.

This page names treatments and does not give doses, because doses in IBD are individual and change with disease activity. The classes involved are aminosalicylates, thiopurines, corticosteroids and biologic therapies, plus methotrexate, which is the clear exception: it is not used in pregnancy and requires planned withdrawal well before conception. Any decision to continue, switch, pause or restart belongs to your gastroenterology team, working with obstetrics, and should be made before you are pregnant wherever possible.

What a flare in pregnancy actually looks like

Distinguishing a flare from ordinary pregnancy bowel changes is genuinely hard. Pregnancy commonly causes looser stools or constipation, urgency, nausea and abdominal cramping, and iron supplements make all of it worse. The features that push towards a flare rather than pregnancy are the ones that would mean a flare outside pregnancy: blood in stool, night-time diarrhoea that wakes you, weight loss, fever, and pain that is progressive rather than fluctuating.

Investigation is not off the table. Stool tests, blood tests including inflammatory markers, and flexible sigmoidoscopy are all used in pregnancy when they will change management. Cross-sectional imaging choices shift towards ultrasound and MRI. The NHS pages on Crohn's disease and ulcerative colitis describe the same underlying conditions and their usual investigations, and the pregnancy-related adjustments are about which test, not whether to investigate.

Anaemia, nutrition and the things that get missed

IBD and pregnancy both deplete iron, and small bowel Crohn's disease can additionally impair absorption of B12 and folate. NICE guideline NG201 on antenatal care sets the routine schedule of haemoglobin testing that applies to everyone, and in IBD the results are more likely to prompt treatment. Ask specifically about ferritin rather than haemoglobin alone if you have had iron problems before, and expect the threshold for intravenous iron to be lower if oral iron worsens your gut symptoms.

Mental health also needs saying out loud. A long-term relapsing condition plus pregnancy is a recognised combination for anxiety, and NICE guideline CG192 asks for mental health to be discussed at the booking appointment and revisited. Raising it is not a distraction from the bowel disease; it is part of the same care.

How your birth is planned

For most people with Crohn's or colitis, vaginal birth remains the default, and Crohn's and Colitis UK says exactly that. Two situations change the conversation:

• Active perianal Crohn's disease, including fistulas or previous complex perianal surgery, where a caesarean is often advised to avoid damage to an already compromised sphincter.
• An ileoanal pouch or ileorectal anastomosis, where the trade-off between protecting continence and avoiding abdominal surgery is individual and needs a colorectal surgeon in the conversation, not just an obstetrician.

Previous abdominal surgery for IBD is relevant to your operative planning, so make sure your operation notes, not just the diagnosis, are known to the maternity team. NICE guideline NG121 sets out how intrapartum care is planned for women with existing medical conditions and asks for a multidisciplinary plan agreed in advance rather than assembled in labour.

What extra monitoring to expect

Expect your usual gastroenterology follow-up to continue in parallel with antenatal care, not to be replaced by it. Growth scans are commonly added where disease has been active, because active inflammation is associated with smaller babies and preterm birth. If you are on a biologic, the timing of your last dose before birth is planned in advance because it affects your baby's live vaccine schedule in the first months, which is a discussion to have with your team well before delivery rather than at the postnatal check.

After the birth

The postnatal months carry a real risk of flare, and it is the period most easily neglected. Agree before birth who is reviewing your IBD and when, how you will get hold of them, and what your plan is if symptoms change. If you are breastfeeding, medicine compatibility is a specific question with a specific answer for each drug, and it is one your gastroenterology team can answer directly rather than something to infer from a leaflet.

Crohn's and Colitis UK maintains detailed patient information on all of this, including reproductive health and fertility, and is a reasonable place to prepare questions before an appointment.

Three questions worth asking before 20 weeks

First, who is the named gastroenterologist for this pregnancy, and how do I contact them between appointments? Second, is my current treatment the one you would choose for the rest of this pregnancy, or is a change planned? Third, does anything about my disease or my previous surgery change how you would advise me to give birth? Getting all three answered while you are well converts a set of unknowns into a plan, and it means the person who meets you in an assessment unit at 34 weeks is reading a decision rather than making one.